SpaceX Files for IPO Expected to Be Largest in History
SpaceX filed paperwork to go public in what analysts expect could be the biggest IPO ever. The company did not disclose a target raise amount but prior reports estimated up to $80 billion.
Financial TimesU.S. regulators on Wednesday to launch an initial public offering that could become the largest in history. The filing did not state how much capital the company seeks to raise. 6 billion raised by Saudi Aramco in 2019.
7 billion. 5 billion. 2 billion. 7 billion on capital projects, mainly data-center construction, and another $3 billion developing its Starship rocket. 7 billion.
Musk controls 85 percent of voting power in SpaceX, according to the filing. After the IPO he is expected to remain chief executive, chief technology officer and board chairman. The company stated its mission is to build systems that make life multiplanetary and extend consciousness to the stars.
" — SpaceX, securities filing, May 2026 SpaceX will list on the Nasdaq under the ticker symbol SPCX. The company did not immediately respond to requests for comment.
Key Facts
Story Timeline
3 events- Apr 2026
SpaceX filed confidential IPO paperwork with the SEC.
2 sourcesNPR · CBS News - May 20, 2026
SpaceX filed detailed financial information with regulators.
3 sourcesFinancial Times · NPR · CBS News - May 20, 2026
Company reported first-quarter results showing $4.3 billion net loss.
1 sourceNPR
Potential Impact
- 01
SpaceX will face increased regulatory scrutiny after going public.
- 02
Ordinary investors will gain ability to buy SpaceX shares.
- 03
The IPO could trigger additional large tech listings later in 2026.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.